Cargando…

SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic, which has seriously affected human health worldwide. The discovery of therapeutic agents is extremely urgent, and the viral structural proteins are particularly important as potential drug targets....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Shilin, Lv, Panpan, Li, Mingxue, Chen, Zihui, Xin, Hong, Reilly, Svetlana, Zhang, Xuemei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Masson SAS. 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832061/ https://www.ncbi.nlm.nih.gov/pubmed/36652729 http://dx.doi.org/10.1016/j.biopha.2023.114242

Ejemplares similares

Olmesartan alleviates SARS-CoV-2 envelope protein induced renal fibrosis by regulating HMGB1 release and autophagic degradation of TGF-β1
por: Zhou, Shilin, et al.
Publicado: (2023)

Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
por: Saravanan, Udhaya Bharathy, et al.
Publicado: (2022)

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
por: Wu, Canrong, et al.
Publicado: (2020)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

SARS-CoV-2: Molecular Structure, Pathogenesis, Potential Therapeutic Targets, and Immune Response of the Infected Subject
por: Wumba, R., et al.
Publicado: (2022)

SARS-CoV-2: From the pathogenesis to potential anti-viral treatments
por: Zarandi, Peyman Kheirandish, et al.
Publicado: (2021)

SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
por: Almehdi, Ahmed M., et al.
Publicado: (2021)

Relevance of SARS-CoV E Protein Ion Channel Activity in Virus Pathogenesis
por: Verdiá Báguena, Carmina, et al.
Publicado: (2015)

Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants
por: Forcados, Gilead Ebiegberi, et al.
Publicado: (2021)

Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
por: Zhou, Hong, et al.
Publicado: (2022)

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
por: Harrison, Andrew G., et al.
Publicado: (2020)

The pathogenesis and alternative treatment of SARS-CoV2
por: Choi, Jun-Yong, et al.
Publicado: (2020)

Epidemiology, transmission and pathogenesis of SARS-CoV-2
por: Sindhuja, Tulasi, et al.
Publicado: (2022)

Potential therapeutic and pharmacological strategies for SARS-CoV2
por: Ghareeb, Doaa A., et al.
Publicado: (2021)

Potential Therapeutic Target and Vaccines for SARS-CoV-2
por: Hussain, Mohamed A., et al.
Publicado: (2023)

Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions
por: Bunders, Madeleine J., et al.
Publicado: (2020)

Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19
por: Sharma, Homa Nath, et al.
Publicado: (2021)

SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
por: Salimi-Jeda, Ali, et al.
Publicado: (2021)

SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment
por: Khalaf, Khalil, et al.
Publicado: (2020)

Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
por: Shah, Taif, et al.
Publicado: (2022)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

Substances of abuse and their effect on SAR-CoV-2 pathogenesis
por: Antwi, Ivy, et al.
Publicado: (2023)

Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice.
por: Schäfer, Alexandra, et al.
Publicado: (2021)

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
por: Klasse, PJ, et al.
Publicado: (2020)

Natural therapeutics against SARS CoV2: the potentiality and challenges
por: Bhar, Anirban, et al.
Publicado: (2022)

Therapeutic potential of compounds targeting SARS-CoV-2 helicase
por: Halma, Matthew T. J., et al.
Publicado: (2022)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
por: Kim, Kwang Su, et al.
Publicado: (2021)

SARS-CoV-2: phylogenetic origins, pathogenesis, modes of transmission, and the potential role of nanotechnology
por: Sahu, Amit Kumar, et al.
Publicado: (2021)

SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
por: McGill, Andrew R., et al.
Publicado: (2021)

Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection
por: Liang, Weizheng, et al.
Publicado: (2022)

Spike Glycoprotein Is Central to Coronavirus Pathogenesis-Parallel Between m-CoV and SARS-CoV-2
por: Saadi, Fareeha, et al.
Publicado: (2021)

Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement
por: Amirfakhryan, Hamideh, et al.
Publicado: (2021)

Pathogenesis and transmission of SARS-CoV-2 in golden Syrian hamsters
por: Sia, Sin Fun, et al.
Publicado: (2020)

Cell and animal models of SARS-CoV-2 pathogenesis and immunity
por: Leist, Sarah R., et al.
Publicado: (2020)

Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis
por: Johnson, Bryan A., et al.
Publicado: (2020)

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis
por: Sun, Shi-Hui, et al.
Publicado: (2020)

Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
por: Johnson, Bryan A., et al.
Publicado: (2022)

SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
por: Kanimozhi, G., et al.
Publicado: (2021)

A review on SARS-CoV-2 and stroke pathogenesis and outcome
por: Roushdy, Tamer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a28mni00mscv5thjogahhm5sqc